HB 16

  • Delaware House Bill
  • 152nd General Assembly (2023-2024)
  • Introduced in House Jun 18, 2024
  • Passed House Jun 11, 2024
  • Passed Senate Jun 30, 2024
  • Governor

An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.

Votes


Jun 30, 2024

Jun 11, 2024

Actions


Jun 30, 2024

Senate

Passed By Senate. Votes: 21 YES

Jun 26, 2024

Senate

Reported Out of Committee (Finance) in Senate with 4 On Its Merits

  • Committee-Passage
Finance

Jun 18, 2024

Senate

Reported Out of Committee (Health & Social Services) in Senate with 5 On Its Merits

  • Committee-Passage
Health & Social Services

Senate

Assigned to Finance Committee in Senate

  • Introduction
  • Referral-Committee
Finance

Jun 11, 2024

House

Passed By House. Votes: 39 YES 2 ABSENT

House

Amendment HA 1 to HB 16 - Passed In House by Voice Vote

Senate

Assigned to Health & Social Services Committee in Senate

  • Introduction
  • Referral-Committee
Health & Social Services

May 22, 2024

House

Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits

  • Committee-Passage
  • Committee-Passage-Favorable
Appropriations

May 21, 2024

House

Amendment HA 1 to HB 16 - Introduced and Placed With Bill

Mar 19, 2024

House

Assigned to Appropriations Committee in House

  • Introduction
  • Referral-Committee
Appropriations

Mar 13, 2024

House

Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits

  • Committee-Passage
  • Committee-Passage-Favorable
Health & Human Development

Feb 29, 2024

House

Introduced and Assigned to Health & Human Development Committee in House

  • Introduction
  • Referral-Committee
Health & Human Development

Bill Text

Bill Text Versions Format
Bill Text PDF HTML
HA 1 to HB 16 HTML PDF

Related Documents

Document Format
Fiscal Note PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.